This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kordick, D. L. Articles by Breitschwerdt, E. B. Search for Related Content PubMed PubMed Citation Articles by Kordick, D. L. Articles by Breitschwerdt, E. B.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother., 11 1997, 2448-2455, Vol 41, No. 11
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats

DL Kordick, MG Papich and EB Breitschwerdt
Department of Companion Animal and Special Species Medicine, College of Veterinary Medicine, North Carolina State University, Raleigh 27606, USA.

Enrofloxacin and doxycycline are antimicrobial agents used to treat bacterial diseases of cats. In vitro susceptibility data indicate that either drug should be effective against Bartonella species. In vivo efficacies of these drugs for eradication of chronic Bartonella henselae or Bartonella clarridgeiae infections were examined in 18 experimentally infected cats and 25 naturally exposed cats treated with enrofloxacin (22.7 mg given orally [PO] every 12 h [q12h] [14 days, n = 10; 28 days, n = 13]) or with doxycycline (25 mg PO q12h [14 days, n = 9; 28 days, n = 8]) or not treated (n = 3). Plasma drug concentrations were determined in experimental cats by high-performance liquid chromatography. Only 23 of 43 cats enrolled ultimately met inclusion criteria. Bacteremia was eliminated for 12 to 25 weeks posttreatment in four of seven cats receiving 14 days of enrofloxacin, five of seven cats receiving 28 days of enrofloxacin, one of six cats receiving 14 days of doxycycline, and one of two cats receiving 28 days of doxycycline. Defining a negative result by blood culture as treatment success may be erroneous; these results may reflect the insensitivity of blood culture or the relapsing nature of Bartonella bacteremia. Our results suggest that MICs obtained with axenic media do not predict antimicrobial activity against intracellular Bartonella, that a long treatment course is required to eliminate infection, and that duration of therapy correlates with pretreatment bacterial load. Given current concern about the development of antimicrobial resistance, we would reserve recommendation for treatment to cats owned by an immunocompromised individual or as an alternative to euthanasia of a pet.

This article has been cited by other articles:

• Angelakis, E., Biswas, S., Taylor, C., Raoult, D., Rolain, J.-M. (2008). Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA. J Antimicrob Chemother 61: 1252-1255 [Abstract] [Full Text]  
• Rolain, J. M., Brouqui, P., Koehler, J. E., Maguina, C., Dolan, M. J., Raoult, D. (2004). Recommendations for Treatment of Human Infections Caused by Bartonella Species. Antimicrob. Agents Chemother. 48: 1921-1933 [Full Text]  
• Rodrick, D., Dillon, B., Dexter, M., Nicholson, I., Marcel, S., Dickeson, D., Iredell, J. (2004). Culture-Negative Endocarditis Due to Houston Complex Bartonella henselae Acquired in Noumea, New Caledonia. J. Clin. Microbiol. 42: 1846-1848 [Abstract] [Full Text]  
• Breitschwerdt, E. B., Blann, K. R., Stebbins, M. E., Munana, K. R., Davidson, M. G., Jackson, H. A., Willard, M. D. (2004). Clinicopathological Abnormalities and Treatment Response in 24 Dogs Seroreactive to Bartonella vinsonii (berkhoffii) Antigens. Journal of the American Animal Hospital Association 40: 92-101 [Abstract] [Full Text]  
• Guptill, L., Wu, C.-C., HogenEsch, H., Slater, L. N., Glickman, N., Dunham, A., Syme, H., Glickman, L. (2004). Prevalence, Risk Factors, and Genetic Diversity of Bartonella henselae Infections in Pet Cats in Four Regions of the United States. J. Clin. Microbiol. 42: 652-659 [Abstract] [Full Text]  
• Yamamoto, K., Chomel, B. B., Kasten, R. W., Hew, C. M., Weber, D. K., Lee, W. I., Droz, S., Koehler, J. E. (2002). Experimental Infection of Domestic Cats with Bartonella koehlerae and Comparison of Protein and DNA Profiles with Those of Other Bartonella Species Infecting Felines. J. Clin. Microbiol. 40: 466-474 [Abstract] [Full Text]  
• Chomel, B. B., Mac Donald, K. A., Kasten, R. W., Chang, C.-C., Wey, A. C., Foley, J. E., Thomas, W. P., Kittleson, M. D. (2001). Aortic Valve Endocarditis in a Dog Due to Bartonella clarridgeiae. J. Clin. Microbiol. 39: 3548-3554 [Abstract] [Full Text]  
• Chopra, I., Roberts, M. (2001). Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiol. Mol. Biol. Rev. 65: 232-260 [Abstract] [Full Text]  
• Breitschwerdt, E. B., Kordick, D. L. (2000). Bartonella Infection in Animals: Carriership, Reservoir Potential, Pathogenicity, and Zoonotic Potential for Human Infection. Clin. Microbiol. Rev. 13: 428-438 [Abstract] [Full Text]  
• Breitschwerdt, E. B., Atkins, C. E., Brown, T. T., Kordick, D. L., Snyder, P. S. (1999). Bartonella vinsonii subsp. berkhoffii and Related Members of the Alpha Subdivision of the Proteobacteria in Dogs with Cardiac Arrhythmias, Endocarditis, or Myocarditis. J. Clin. Microbiol. 37: 3618-3626 [Abstract] [Full Text]  
• Kordick, D. L., Brown, T. T., Shin, K., Breitschwerdt, E. B. (1999). Clinical and Pathologic Evaluation of Chronic Bartonella henselae or Bartonella clarridgeiae Infection in Cats. J. Clin. Microbiol. 37: 1536-1547 [Abstract] [Full Text]